Renal cell osteopontin production is stimulated by calcium oxalate monohydrate crystals

Kidney International

Volumn 51, Issue 3, 1997, Pages 679-686

  Lieske, John C ^a   Hammes, Mary S ^b   Hoyer, John R ^b   Toback, F Gary ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOPONTIN; WHEWELLITE;

ANIMAL CELL; ARTICLE; CRYSTALLIZATION; KIDNEY CELL; KIDNEY CELL CULTURE; KIDNEY TUBULE; MONKEY; NONHUMAN; PRIORITY JOURNAL; STONE FORMATION;

EID: 0030889633     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/ki.1997.98     Document Type: Article

References (58)

1. COE FL, PARKS JH: Nephrolithiasis: Pathogenesis and Treatment (2nd ed). Chicago, Year Book Medical Publishers, 1988, p 1
2. LIESKE JC, LEONARD R, TOBACK FG: Adhesion of calcium oxalate monohydrate crystals to renal epithelial cells is inhibited by specific anions. Am J Physiol 268:F604-F612, 1995
3. LIESKE JC, LEONARD R, SWIFT HS, TOBACK FG: Adhesion of calcium oxalate monohydrate crystals to anionic sites on the surface of renal epithelial cells. Am J Physiol 270:F192-F199, 1996
4. RIESE RJ, RIESE JW, KLEINMAN JG, WIESSNER JH, MANDEL GS, MANDEL NS: Specificity in calcium oxalate adherence to papillary epithelial cells in culture. Am J Physiol 255:F1025-F1032, 1988
5. RIESE RJ, MANDEL, NS, WIESSNER JH, MANDEL GS, BECKER CG, KLEINMAN JG: Cell polarity and calcium oxalate crystal adherence to cultured collecting duct cells. Am J Physiol 262:F177-F184, 1992
6. LIESKE JC, WALSH-REITZ MM, TOBACK FG: Calcium oxalate monohydrate crystals are endocytosed by renal epithelial cells and induce proliferation. Am J Physiol 262:F622-F630, 1992
7. LIESKE JC, SWIFT HS, MARTIN T, PATTERSON B, TOBACK FG: Renal epithelial cells rapidly bind and internalize calcium oxalate monohydrate crystals. Proc Natl Acad Sci USA 91:6987-6991, 1994
8. HAMMES MS, LIESKE JC, PAWAR S, SPARGO BH, TOBACK FG: Calcium oxalate monohydrate crystals stimulate gene expression in renal epithelial cells. Kidney Int 48:501-509, 1995
9. VERKOELEN CF, ROMIJN JC, DEBRUTIN C, BOEVÉ ER, CAO L-C, SCHRÖDER FH: Association of calcium oxalate monohydrate crystals with MDCK cells. Kidney Int 48:129-138, 1995
10. LIESKI JC, TOBACK FG: Regulation of renal epithelial cell endocytosis of calcium oxalate monohydrate crystals. Am J Physiol 264:F800-F807, 1993
11. VERKOELEN CF, ROMIJN JC, CAO LC, BOEVÉ ER, DE BRUIJN WC, SCHRÖDER FH: Crystal-cell interaction inhibition by polysaccharides. J Urol 155:749-752, 1996
12. DENHARDT DT, GUO X: Osteopontin: A protein with diverse functions. FASEB J 7:1475-1482, 1993
13. SHIRAGA H, MIN W, VANDUSEN WJ, CLAYMAN MD, MINER D, TERRELL CH, SHERBOTIE JR, FOREMAN JW, PRZYSIECKI C, NEILSON EG, HOYER JR: Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acid-rich protein super-family. Proc Natl Acad Sci USA 89:426-430, 1992
14. PATARCA R, SAAVEDRA RA, CANTOR H: Molecular and cellular basis of genetic resistance to bacterial infection: The role of the early T-lymphocyte activation/osteopontin gene. Crit Rev Immunol 13:225-246, 1993
15. FLORES ME, NORGARD M, HEINEGARD D, RIENHOLT FP, ANDERSSON G: RGD-directed attachment of isolated rat osteoclasts to osteopontin, bone sialoprotein, and fibronectin. Exp Cell Res 201:526-530, 1992
16. MIYAUCHI A, ALVAREZ J, GREENFIELD EM, TETI A, GRANO M, COLUCCI S, ZAMBONIN-ZALLONE A, ROSS FP, TEITELBAUM SL, CHERISH D, HRUSKA KA: Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem 266:20369-20374, 1991
17. i in rat osteoclasts and mouse-derived osteoclast-like cells. Am J Physiol 266:C376-C381, 1994
18. NAKAGAWA Y, MARGOLIS HC, YOKOYAMA S, KEZDY FJ, KAISER ET, COE FL: Purification and characterization of a calcium oxalate monohydrate crystal growth inhibitor from human kidney tissue culture medium. J Biol Chem 256:3936-3944, 1981
19. CHOMCZYNSKI P, SACCHI N: Single-step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction. Anal Biochem 162:156-159, 1983
20. FEINBERG AP, VOGELSTEIN B: A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983
21. WAHL GM, STERN M, STARK GE: Efficient transfer of large DNA fragments from agarose gels to diazobenzloxymethyl paper and rapid hybridization by using dextran sulfate. Proc Natl Acad Sci USA 76:3683-3687, 1979
22. 3. J Biol Chem 270:9917-9925, 1995
23. 5. J Biol Chem 270:26232-26238, 1995
24. SMITH JH, DENHARDT DT: Molecular cloning of a tumor promoter-inducer mRNA found in JB6 mouse epidermal cells: Induction is stable at high, but not low, cell densities. J Cell Biochem 34:13-22, 1987
25. FISHER LW, HAWKINS GR, TUROSS N, TERMINE JD: Purification and partial characterization of small proteoglycans I and II, bone sialo-proteins I and II, and osteonectin from the mineral compartment of developing human bone. J Biol Chem 262:9702-9708, 1987
26. PRINCE CW, OASAWA T, BUTLER WT, TOMANA M, BHOWN AS, BHOWN M, SCHROHENLOHER RE: Isolation, characterization and biosynthesis of a phosphorylated glycoprotein fom rat bone. J Biol Chem 262:2900-2907, 1987
27. CRAIG AM, NEMIR M, MUKHERJEE BB, CHAMBERS AF, DENHARDT DT: Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: Enhanced expression in H-ras-transformed 3T3 cells. Biochem Biophys Res Commun 157:166-173, 1988
28. SENGER DR, PERUZZI CA, GRACEY CF, PAPADOPOULOS A, TENEN DG: Secreted phosphoproteins associated with neoplastic transformation: Close homology with plasma proteins cleaved during blood coagulation. Cancer Res 48:5770-5774, 1988
29. NEMIR N, DEVOUGE MW, MUKHERJEE BB: Normal rat kidney cells secrete both phosphorylated and nonphosphorylated forms of osteopontin showing different physiological properties. J Biol Chem 264:18202-18208, 1989
30. PATARCA R, FREEMAN GJ, SINGH RP, WEI FY, DURFEE T, BLATTNER F, REGNIER DC, KOZAK CA, MOCK BA, MORSE HC: Structural and functional studies of the early T lymphocyte activation (Eta-1) gene. J Exp Med 170:145-162, 1989
31. LOPEZ CA, HOYER JR, WILSON PD, WATERHOUSE P, DENHARDT DT: Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab Invest 69:355-363, 1993
32. KLEINMAN JG, BESHENSKY A, WORCESTER EM, BROWN D: Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney, Kidney Int 47:1585-1596, 1995
33. KOHRI K, NOMURA S, KITAMURA Y, NAGATA T, YOSHIOKA K, IGUCHI M, YAMATE T, UMEKAWA T, SUZUKI Y, SINOHARA H, KURITA T: Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem 268:15180-15184, 1993
34. GIACHELLI CM, PICHLER R, LOMBARDI D, DENHARDT DT, ALPERS CE, SCHWARTZ SM, JOHNSON RJ: Osteopontin expression in angiotensin II-induced tubulointerstital nephritis. Kidney Int 45:515-524, 1994
35. WORCESTER EM, BLUMENTHAL SS, BESHENSKY AM. LEWAND DL: The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res 7:1029-1036, 1992
36. SINGH K, MUKHERJEE AB, DEVOUGE MW, MUKHERJEE BB: Differential processing of osteopontin transcripts in rat kidney- and osteoblast-derived cell lines. J Biol Chem 267:23847-23851, 1992
37. ULLRICH O, MANN K, HAASE W, KOCH-BRANDT C: Biosynthesis and secretion of an osteopontin-related 20-kDa polypeptide in the Madin-Darby canine kidney cell line. J Biol Chem 266:3518-3525, 1991
38. FINLAYSON B, REID S: The expectation of free and fixed particles in urinary stone disease. Invest Urol 15:442-448, 1978
39. KOK DJ, KHAN SR: Calcium oxalate nephrolithiasis, a free or fixed particle disease. Kidney Int 46:847-854, 1994
40. KHAN SR, COCKRELL CA, FINLAYSON B, HACKETT RL: Crystal retention by injured urothelium of the rat urinary bladder. J Urol 132:153-157, 1984
41. GILL WB, JONES KW, RUGGIERO KJ: Protective effects of heparin and other sulfated glycosaminoglycans on crystal adhesion to injured urothelium. J Urol 127:152-154, 1982
42. JOHNSON RJ, ALPERS CE, YOSHIMURA A, LOMBARDI D, PRITZL P, FLOEGE J, SWARTZ SM: Renal injury form angiotensin II-mediated hypertension. Hypertension 19:464-474, 1992
43. SINGH RP, PATARCA R, SCHWARTZ J, SINGH P, CANTRE H: Definition of a specific interaction between the early T lymphocyte activation 1 (Eta-1) protein and murine macrophages in vitro and its effect upon human macrophages in vivo. J Exp Med 171:1931-1942, 1990
44. HOCKADAY TDR, CLAYTON JE, FREDERICK EW: Primary hyperoxaluria. Medicine 43:315-345, 1964
45. KOTEN JW, VAN GASTEL C, DORHOUT MEES EJ, HOLLEMAN LWJ, SCHUILING RD: Two cases of primary oxalosis. J Clin Pathol 18:223-229, 1965
46. SAXON A, BUSCH GJ, MERRILL JP, FRANCO V, WILSON RE: Renal transplantation in primary hyperoxaluria. Arch Intern Med 133:464-467, 1974
47. SALYER WR, KEREN D: Oxalosis as a complication of chronic renal failure. Kidney Int 4:61-66, 1973
48. FAYEMI AO, ALI M, BRAUN EV: Oxalosis in hemodialysis patients. A pathologic study of 80 cases. Lab Med 103:58-62, 1979
49. ZAREMBSKI PM, HODGKINSON A, PARSONS FM: Elevation of the concentration of plasma oxalic acid in renal failure. Nature 212:511-512, 1966
50. WORCESTER EM, NAKAGAWA Y, BUSHINSKY DA, COE FL: Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest 77:1888-1896, 1986
51. BOER P, VAN LEERSUM L, HENE RJ, MEES EJ: Plasma oxalate concentration in chronic renal disease. Am J Kidney Dis 4:118-122, 1984
52. BENNETT B, ROSENBLUM C: Identification of calcium oxalate crystals in the myocardium in patients with uremia. Lab Invest 10:947-955, 1961
53. MORGAN SH, PURKISS P, WATTS RWE, MANSELL MA: Oxalate dynamics in chronic renl failure. Comparison with normal subjects and patients with primary hyperoxaluria. Nephron 46:253-257, 1987
54. BOHLE A, MACKENSIN-HAEN S, GISE H, GRUND RE, WEHRMAN M, BATZ CH, BORGENSCHULZ O, SCHMITT H, NAGY J, MILLER C, MILLER G: The consequences of tubulo-interstitial changes for renal function in glomerulonephritis. Pathol Res Pract 186:135-144, 1988
55. RISDOM RA, SLOPER JC, DE WARDENER HE: Relationship between renal function and histologic changes found in renal biopsy specimens from patients with persistent glomerulonephritis. Lancet 1:363-366, 1968
56. STRIKER GE, SCHALNUCK LI, CUTLER RE, BENDITT EP: Structural-functional correlations in renal disease. Part 1: A method for assaying and classifying histopathologic changes in human tissue. Hum Pathol 1:615-630, 1970
57. SCHAINUCK LI, STRIKER GE, CUTLER RE, BENDITT EP: Structural-functional correlations in renal disease. Part II: The correlations. Hum Pathol 1:631-641, 1970
58. HOOKE DH, DEE DC, ATKINS RC: Leukocyte analysis using monoclonal antibodies in human glomerulonephritis. Kidney Int 31:964-972, 1987